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In Nigeria, Community Pharmacists (CPs) and Patent 
and Proprietary Medicine Vendors (PPMVs) are the first 
point of care for many communities. Although CPs and 
PPMVs are not formally recognized as FP service 
providers, 22% of modern contraceptive users’ report 
receiving their last method from a PPMV and 12%  from 
a private pharmacy [2]. PPMVs are especially popular for 
family planning (FP) due to their widespread availability, 
consistent drug stocks, extended hours, personable 
interactions, and no separate fees for consultations [3, 
4]. As the Federal Ministry of Health (FMoH) explores 
expanding its task sharing policy to include CPs and 
PPMVs, evidence is needed on an effective regulatory 
system to support PPMVs and CPs to provide high 
quality FP services. 
THE INTEGRATE PROJECT 
The IntegratE Project is a 4-year initiative (2017-2021) 
funded by the Bill & Melinda Gates Foundation and MSD 
for Mothers1 that seeks to increase access to 
contraceptive methods by involving the private sector 
(CPs and PPMVs) in FP service delivery in Lagos and 
Kaduna States. IntegratE is implemented by a 
consortium of partners, Marie Stopes International, 
Planned Parenthood Federation of Nigeria, Population 
Council, PharmAccess, and led by the Society for Family 
Health. The project seeks to establish a regulatory 
system with the Pharmacists Council of Nigeria (PCN) to 
ensure that CPs and PPMVs provide quality FP services, 
comply with FP regulations and report service statistics 
to the Health Information Management System (HMIS). 
To achieve this, the IntegratE Project in collaboration 
 
1 1 This programme is co-funded by, developed and is being 
implemented in collaboration with MSD for Mothers, MSD’s $500 
million initiative to help create a world where no woman dies giving 
life. MSD for Mothers is an initiative of Merck & Co., Inc., Kenilworth, 











 with PCN and the FMoH, is implementing three main 
activities: (1) a pilot 3-tiered accreditation system for 
PPMVs based on their healthcare qualifications; (2) a 
pilot hub-and-spoke supervisory model to ensure 
standard drug stocking practices; and (3) building the 
capacity of CPs and PPMVs to provide expanded FP 
services and report service statistics to the HMIS. Under 
the pilot accreditation system, PPMVs are provided with 
a standardized FP training and offer certain FP services 
based on their tier (Table 1). CPs function outside of the 
pilot accreditation system but would receive the same 
training and provide the same services as Tier 2 PPMVs. 
The IntegratE Project is simultaneously raising 
awareness about the FP services CPs and PPMVs 
provide. This brief focuses on quality of care received by 
women voluntarily seeking FP services from CPs and 
PPMVs. Additional information on IntegratE Project can 






Table 1: Description of tier accreditation system  
Provider 
type 






• FP counseling and referral 






• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
Tier 3 
PPMVs 
PPMVs who are 
also pharmacy 
technicians  
• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
CPs Outside of 
accreditation 
system 
• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
THE MAJORITY OF WOMEN (98%) FELT 
THAT THEY WERE ALLOWED TO ASK 
QUESTIONS DURING THEIR FP 
COUNSELING SESSIONS WITH CPS 
AND PPMVS 
 
Quality of care received for family planning 
from Community Pharmacists and Patent and 
Proprietary Medicine Vendors in Lagos and 

















QUALITY OF CARE RECEIVED BY 
CLIENTS SEEKING FAMILY 
PLANNING SERVICES FROM CPS 
AND PPMVS 
The IntegratE project is conducting a mixed-methods 
study to assess the effect of a series of interventions on 
CPs’ and PPMVs’ capacity to provide high quality FP 
services. Between June and November of 2019, women 
were interviewed after receiving FP services from 
trained CPs and PPMVs. 598 women who received FP 
services from CPs in Kaduna and Lagos states were 
contacted within a week of receiving services by a data 
collector by phone about the services that they received. 




Just over half of women interviewed were between the 
ages of 25 and 34 (54%) in Kaduna, and 35 or older 
(53%) in Lagos. Nearly all women in both states were 
married or in-union (95% in Kaduna and 93% in Lagos) 
and had at least one child (96% in Kaduna and 97% in 
Lagos). Most had completed secondary school or higher 




Quality of care received 
The measures of quality of care assessed in this study 
are broken down into four key domains [6]: 1) respectful 
care, 2) method selection, 3) effective use of selected 
method, and 4) continuity of contraceptive use and care. 
Figure 1 presents the proportions of women who 
reported high quality by domain (n=4972). Respectful 
care includes interpersonal interactions between the 
provider and woman and assesses aspects of privacy 




2 101 women were inadvertently skipped from the quality of care 
questions 
 
quality of care for 5 of the 6 items in the respectful care 
domain. Nearly all women felt that they were treated well 
by the provider (99% in Kaduna and 100% in Lagos) and 
that their information would be kept confidential (99% 
in Kaduna and 96% in Lagos). Fewer in each state felt 
that audio privacy was ensured during the visit (88% in 
Kaduna and 91% Lagos), and that visual privacy was 
ensured (66% in Kaduna and 74% Lagos). 
 
Method selection focuses on information sought by 
providers  to facilitate women’s choice of method. At 
least 90% of women in both states reported discussion 
of 4 of the 7 items related to method selection. For 
example, most women reported that the provider told 
them about other FP methods (96% in each state) and 
asked about their preferred method (95% in Kaduna 
and 96% in Lagos). Fewer women reported aspects of 
quality for the other 3 items. For example, providers 
were trained not to promote any one method.  Interviews 
showed that in Lagos, 87% of women reported that no 
method was strongly promoted, and 70% reported this 
in Kaduna. Sixty-eight percent of women in Kaduna and 
58% in Lagos reported that the provider gave them 
information about FP methods that protect against STIs. 
 
 








     16-24 22.2 5.0 13.6 
     25-34 54.0 42.3 48.2 
     35-53 23.8 52.7 38.3 
Marital Status* 
     Single 4.4 5.3 4.9 
     Married/ In-union 94.6 93.3 94.0 
     Widowed/divorced 0.7 1.3 1.0 
Number of living children*    
     None 4.0 3.3 3.7 
     One 10.4 9.7 10.0 
     Two 23.2 15.0 19.1 
     Three 20.8 35.0 27.9 
     Four or more 41.3 37.0 39.1 
Highest level of education achieved* 
     No formal education 12.8 3.3 8.0 
     Primary 18.8 14.0 16.4 
     Secondary  49.0 41.7 45.3 
     2+ years post-secondary 18.5 37.7 28.1 
*Percentages do not total to 100% due to missing observations 
WOMEN REPORTED RECEIVING A 
RANGE OF INFORMATION ABOUT 
METHOD SELECTION, FROM A HIGH OF 
96% WHO WERE TOLD ABOUT OTHER 
FP METHODS TO A LOW OF 58% IN 
LAGOS WHO WERE TOLD ABOUT 



















Effective use of the selected method includes 
information about how to safely and effectively use the 
method. Most women reported that the provider told 
them how their chosen method works (96% in Kaduna 
and 94% in Lagos) and how to use it (95% in Kaduna 
and 92% in Lagos). Fewer reported that the provider told 
them about the possible side effects of the chosen 
method (78% in Kaduna and 66% in Lagos) and how to 
manage those side effects (72% in Kaduna and 61% in 
Lagos). 
 
FOR THEIR CHOSEN METHOD, 78% OF 
WOMEN IN KADUNA AND 67% IN LAGOS 
WERE TOLD ABOUT POSSIBLE SIDE 
EFFECTS AND 72% OF WOMEN IN 
KADUNA AND 61% OF WOMEN IN LAGOS 
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Told about the possibility of switching method
Told about other sources of FP supply
Given appointment card for follow up visit
Told about timing of next visit
Told how to manage side effects/problems
Told about possible side effects of chosen method
Told about warning signs associated with method
Told how to use chosen method
Told how chosen method works
Received information on methods that protect against STIs
Received information without any method promoted
Asked about preferred timing of next child
Asked about desire for another child
Asked about previous FP experience
Asked about preferred FP method
Told about other methods
Felt visual privacy
Felt audio privacy
Felt information will be kept confidential
Allowed to ask questions
Questions answered to satisfaction
























































































Kaduna n=249 Lagos n=248



















Continuity of contraceptive use and care includes 
information about follow-up appointments and the 
ability to switch to other methods. Most women were 
told about the timing of their next FP visit (95% in 
Kaduna and 90% in Lagos). Many were told that they 
could switch to another method if the method selected 
wasn’t suitable (89% in Kaduna and 82% in Lagos) and 
about other sources of FP supply (84% in Kaduna and 
80% in Lagos).   
Level of quality of care received by 
women seeking family planning from CPs 
and PPMVs 
A composite scale combining the 22-items into low, 
medium and high quality of care received was 
calculated based on methods used in previous studies 
[7]. Forty percent of women were categorized as 
receiving high quality of care, 36% as medium quality of 







3 (n=563) 35 women were inadvertently skipped from these 
questions 
 
In addition, 97% of women said they would return to the 
same CP or PPMV for FP in the future, and 98% said they 
would recommend the same provider to a friend3. 
 
CONCLUSION 
Results to date suggest that just over three-quarters of 
women seeking FP services from IntegratE-trained CPs 
and PPMVs received medium to high quality of care. 
These findings are promising for the ability of CPs and 
PPMVs to provide high quality care to clients seeking FP 
services in Nigeria. The IntegratE Project plans to use 
these results to help inform future FP counseling 
trainings and mentorship support to CPs and PPMVs to 
ensure that women seeking services from CPs and 
PPMCs continue to receive high quality services. 
Through additional client exit interviews planned for 
Year 3 of the project, changes in quality of care received 
from trained CPs and PPMVs will be assessed.  
MORE THAN THREE-QUARTERS OF 
WOMEN REPORTED RECEIVING EACH 
ITEM IN THE CONTINUITY OF 
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